July 27, 2011 /
Now Available Online at www.neurologyreviews.com
Clinical Reviews of JCV and PML:
Understanding the Complexities of JCV and PML
Clinical Reviews of JCV and PML:
Understanding the Complexities of JCV and PML
This new supplement to Neurology Reviews provides important, up-to-date information on the risk of progressive multifocal leukoencephalopathy (PML) in patients taking immunomodulating drugs.
Three leading experts—Mark Gudesblatt, MD; John F. Foley, MD; and Moti L. Chapagain, PhD—discuss the link between JC virus and PML, the epidemiology of PML, risk stratification for patients taking natalizumab and other immunomodulating agents, and current survival statistics.
Supplement sponsored by Biogen Idec.
Look for this important publication online at www.neurologyreviews.com
..
.===========================================================
Disclaimer: ‘MS Views and News’ (MSVN), does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.www.neurologyreviews.com
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews
Stay informed with MS news and information - Sign-up here
For MS patients, caregivers or clinicians, Care to chat about MS? Join Our online COMMUNITY CHAT
